About 46,XY difference of sex development due to 5-alpha-reductase 2 deficiency
46,XY difference of sex development due to 5-alpha-reductase 2 deficiency is a rare disease catalogued by Orphanet (ORPHA:753). It is associated with the SRD5A2 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to 46,XY difference of sex development due to 5-alpha-reductase 2 deficiency trials.
Search ClinicalTrials.gov for "46,XY difference of sex development due to 5-alpha-reductase 2 deficiency" or filter by Orphanet code ORPHA:753 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting 46,XY difference of sex development due to 5-alpha-reductase 2 deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for 46,XY difference of sex development due to 5-alpha-reductase 2 deficiency. Updated daily.